Keith Kendall

Keith Kendall

No más puestos en curso

Fortuna: 3 M $ al 31/03/2024

66 años
Health Technology
Consumer Services
Electronic Technology

Perfil

Keith J.
Kendall
served as President, Chief Executive Officer & Director at Aquestive Therapeutics, Inc. from 2014 to 2022.
Prior to that, he was Vice President & Managing Director at Hewlett-Packard Financial Services Co. from 1999 to 2006.
He also served as Non-Executive Director at Biodexa Pharmaceuticals Plc from 2010 to 2014.
Before his time at Hewlett-Packard, he was President at CIT Communications Finance Corp.
and NCR Credit Corp.
from 1985 to 1998.
Kendall holds an MBA from Pace University and an undergraduate degree from St. John's University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
15/03/2023 637 149 ( 0.71% ) 3 M $ 31/03/2024

Antiguos cargos conocidos de Keith Kendall.

EmpresasCargoFin
FEMASYS INC. Director/Board Member 08/11/2023
AQUESTIVE THERAPEUTICS, INC. Chief Executive Officer 17/05/2022
BIODEXA PHARMACEUTICALS PLC Director/Board Member 01/12/2014
Corporate Officer/Principal 01/06/2006
President -
Ver el detalle de la experiencia de Keith Kendall.

Formación de Keith Kendall.

Pace University Masters Business Admin
St. John's University Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Keith Kendall.

Relaciones

40

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas3
FEMASYS INC.

Electronic Technology

AQUESTIVE THERAPEUTICS, INC.

Health Technology

BIODEXA PHARMACEUTICALS PLC

Health Technology

Empresas privadas3

Commercial Services

Finance

NCR Credit Corp.

Ver las conexiones de la empresa